Attention improved in more than 80 percent of adults with ADHD, and over one-third of participants no longer exhibited an attention deficit following treatment Improvements in attention were nearly ...

The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.

Attention improved in more than 80 percent of adults with ADHD, and over one-third of participants no longer exhibited an attention deficit following treatment Improvements in attention were nearly ...

A recent study of the video-game-based treatment that focused on adults with ADHD found that EndeavorRx boosted their sustained and selective attention at a rate nearly seven times that of the ...

EndeavorRx is authorized for use to improve attention function in adolescents with primarily inattentive or combined-type ADHD. The Food and Drug Administration (FDA) has expanded the approval of ...

Can we develop a brain test for detecting ADHD? Source: Image by A Danvers Several years ago, I was sitting around with some friends talking about our (occasional) difficulties paying attention. This ...

Akili (NASDAQ:AKLI) stock rose ~38% on Wednesday after the company reported results from a trial of video game-based therapy EndeavorRx to treat adults with attention ...

Please provide your email address to receive an email when new articles are posted on . A digital medicine company has revealed positive topline results of an expansionist study evaluating the ...

Attention improvements were nearly three times as large as those in the pivotal trial that served as the basis for EndeavorRx’s FDA authorization for children with ADHD ages 8-12 Study data will be ...

SAN FRANCISCO--(BUSINESS WIRE)--Lumos Labs, creators of the popular Lumosity brain training platform with over 100 million users, announced today that the U.S. Food and Drug Administration (FDA) has ...

There are now 2.6 million people in the UK with ADHD – and diagnoses are on the rise. Looking at 18 years of anonymised NHS patient records, researchers at University College London noted a 20-fold ...